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Abstract
Background:  Instruments designed to measure the subjective impact of painful shoulder
conditions have become essential in shoulder research. The Shoulder Pain and Disability Index
(SPADI) is one of the most extensively used scales of this type. The objective of this study was to
investigate reproducibility and responsiveness of the SPADI in patients with adhesive capsulitis.
Methods:  SPADI test-retest reproducibility was estimated by the "intraclass correlation
coefficient" (ICC) and the "smallest detectable difference" (SDD). Responsiveness was assessed by
exploring baseline and follow-up data recorded in a recently reported clinical trial regarding
hydrodilatation and corticosteroid injections in 76 patients with adhesive capsulitis. "Standardized
response mean" (SRM) and "reliable change proportion" (RCP) for SPADI were compared with
corresponding figures for shoulder range-of-motion (ROM). The relationship between SPADI and
ROM change scores was investigated through correlation and linear regression analyses.
Results: Results for test-retest reproducibility indicated a smallest detectable difference of 17
points on the 0–100 scale, and an intraclass correlation coefficient of 0.89. The SPADI was generally
more responsive than ROM. Weak to moderately strong associations were identified between
SPADI and ROM change scores. According to the regression model, the three variables baseline
SPADI, baseline active ROM and change in active ROM together explained 60% of the variance in
SPADI improvement.
Conclusion: This study supports the use of SPADI as an outcome measure in similar settings.
Background
The Shoulder Pain and Disability Index (SPADI) is a self-
administered questionnaire consisting of items grouped
into pain and disability subscales. Rating is on visual ana-
logue scales, and the means of the two subscales are com-
bined to produce a total score ranging from 0 (best) to
100 (worst). The SPADI was designed to measure the
impact of shoulder pathology in terms of pain and disa-
bility, for both current status and change over time. The
original developers stated the rationale for developing this
type of joint-specific instrument: it was expected to meas-
ure the impact of specific joint problems more precisely
than global health assessment instruments, and also to be
better in demonstrating the effect of a treatment directed
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at one joint only [1]. These properties are closely linked to
responsiveness, defined as the ability of an instrument to
accurately detect change when it has occurred [2].
Responsiveness of the SPADI has been assessed using ret-
rospective self-assessment of global change as a reference
criterion, a study [3] cited by several researchers. Patients
were given their baseline responses when follow-up
SPADI scores were recorded along with the global rating
of change. Then the SPADI change score was compared to
the measure of global change, where the patient had rated
his shoulder problem as "cured", "improved", "the same"
or "worse" compared to his baseline examination. Based
on these comparisons, the authors stated that "the SPA-
DIΔ (baseline – follow-up) discriminated accurately
between subjects who improved versus those who stayed
the same or worsened" [3]. This statement regarding
SPADI responsiveness can hardly be expected to apply to
settings in clinical trials where more traditional designs
are used when gathering follow-up scores. Retrospective
methods of computing responsiveness yield little infor-
mation about the ability of an instrument to detect treat-
ment effects, and they should not be used as a basis for the
choice of an instrument for applications to clinical trials
[4,5].
SPADI responsiveness has been compared with the
responsiveness of other health assessment scales, both
global [6-10] and shoulder-specific [8-11]. SPADI is
reported to be one of the more responsive scales [12]. It is,
however, problematic to make conclusions on respon-
siveness based on comparisons only with such very simi-
lar types of instruments.
A considerable number of shoulder self-report question-
naires have been proposed [13]. The rationale for their
employment in research settings must be that there are
advantages concerning the properties of the new instru-
ments. This obvious criterion often seems to be ignored.
As a consequence, a variety of instruments sometimes
makes it a complex task to interpret the results of trials.
Furthermore, for most of the shoulder questionnaires, evi-
dence for their validity in various diagnostic groups used
in clinical trials is often limited, at best. The SPADI is no
exception to this, even though it is one of the shoulder rat-
ing instruments that have been most extensively studied
[12]. It has also been employed in several clinical trials
involving patients with adhesive capsulitis [14-18].
The objective of this study is to investigate reproducibility
and responsiveness of the SPADI when evaluating
patients with adhesive capsulitis (See Additional file 1 for
the Norwegian version [19] of the SPADI). Reproducibil-
ity is assessed with a test-retest of presumably "stable"
patients. Responsiveness is investigated by using baseline
and follow-up scores from a recently reported clinical trial
regarding hydrodilatation and corticosteroid injections in
patients with adhesive capsulitis [20]. Subjects included
in the clinical trial were outpatients attending the Depart-
ment of Physical Medicine and Rehabilitation of Ullevål
University Hospital in the period Dec. 2003 – June 2005.
A hydrodilatation procedure including corticosteroids
was compared with the injection of corticosteroids with-
out hydrodilatation. Patients were given three injections
with two-week intervals, and all injections were given
under fluoroscopic guidance. Seventy-six patients were
included and groups were compared six weeks after treat-
ment in order to identify potential treatment effects of
hydrodilatation. The main inclusion criteria were shoul-
der pain and reduction of passive ROM in the affected
shoulder of 30° or more for at least two out of three
glenohumeral movements (flexion, abduction and exter-
nal rotation).
There are several aspects of responsiveness [2], reflecting
the different ways instruments are used in various settings.
"Internal" [21] responsiveness statistics refer to the ability
to produce statistically significant changes in scores,
dependent on the study population and intervention.
Interpretation of SPADI "internal" responsiveness figures
is facilitated in this study by reporting corresponding fig-
ures for shoulder ROM, thereby allowing for head-to-head
comparisons of SPADI and a more traditional outcome
measure [22] for shoulder capsulitis.
Responsiveness can also be measured in terms of the
strength of the relationship between changes in the out-
come measure of interest and changes in some external
standard, e.g. important clinical variables. This aspect of
responsiveness is called "external" responsiveness [21].
Previous researchers have investigated the relationship
between shoulder ROM and shoulder scales in cross-sec-
tional analyses [11,23-27], while our aim is to compare
change scores. In general, we expect associations of mod-
erate strength. We expect association with SPADI to be
stronger for measures of active ROM than for passive
ROM, and we expect stronger associations for the disabil-
ity subscale than for the pain subscale.
Methods
The regional ethics committee granted ethical approval
for the trial. The procedures followed protocol and com-
plied with the Helsinki Declaration as revised in 1983 and
current national ethical standards for such studies.
Translation
Translation of items was based on recommended guide-
lines [28]. Two teams of translators with Norwegian as
their mother tongue made the first forward translations.
Two back-translations were then made by professionalBMC Musculoskeletal Disorders 2008, 9:161 http://www.biomedcentral.com/1471-2474/9/161
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translators with English as their mother tongue. A com-
mittee reviewed the source and final versions. Forward
and back-translations of the SPADI revealed no major dif-
ficulties and consensus was reached on a preliminary Nor-
wegian version. This version was pre-tested in a group of
patients before a final version was available for the present
study.
Measurements
The SPADI is divided into two subscales: a "pain" subscale
and a "disability" subscale. The subscales comprise series
of 5 items for "pain" and 8 items for "disability", referring
to various problems with their shoulder encountered over
the last week. Reported scoring procedures vary slightly in
different validity studies [1,3,29]. In this study, each item
is responded to by a visual analogue scale ranging from
"no pain"/"no difficulty", to "worst pain imaginable"/"so
difficult required help". Item scores for each section are
averaged to produce separate subscale scores ranging from
0 to 100. A SPADI total score ranging from 0 (best) to 100
(worst) is then produced by averaging the two subscale
scores. If more than two items of a subscale are not
responded to, no SPADI score is calculated. Within-
patient comparisons over time are based on items that
were scored on both occasions.
SPADI reproducibility in presumably stable patients is
assessed by administering the SPADI two times to each
patient with a one-week interval. This time interval was
chosen because it seemed long enough for the responder
to forget previous scoring details, yet short enough to
avoid any important change occurring in patients with
this long-lasting condition [30,31]. No patient started any
new treatment in this one-week period.
Along with SPADI, scores for active and passive shoulder
ROM in four different directions were gathered at baseline
and follow-up (as part of the clinical trial): abduction
(ABD) and flexion (FLE) from neutral, and internal (INT)
and external (EXT) rotation at 45° of abduction. For the
present study, scores for the four directions were com-
bined to produce overall measures of active (C.AROM)
and passive (C.PROM) range-of-motion for each patient.
ROM measurements were made according to a pre-speci-
fied protocol [32].
Statistical procedures
Calculation of SPADI reproducibility in stable patients is
based on the within-patient standard deviation (sw),
derived from a one-way analysis of variance (ANOVA).
We report the "smallest detectable difference", defined as
SDD = 1.96 sw x √ 2 = 2.77 sw (ref. "repeatability" [33],
"minimum detectable change" [6,34]). The difference
between two measurements for the same patient is
expected to be less than the SDD for 95% of pairs of obser-
vations [33]. The calculation of a common standard devi-
ation for the measurements is based on the absence of
heteroscedasticity [35]. Heteroscedasticity refers to a situ-
ation in which measurement errors are dependent on the
size of the various readings. We investigated the relation-
ship between test-retest differences and SPADI means for
each patient by using Bland-Altman plots [33].
Reproducibility is also reported by use of the intraclass
correlation coefficient (ICC). While SDD refers to the
absolute difference between observations, ICC is the cor-
relation between observations [36]. ICC is computed
using a one-way ANOVA model (single measures). ICC
values can theoretically range from 0 to 1, a high ICC in
this case indicating that within-patient differences are
small as compared to between-patient variability in the
study population.
Group level "internal" responsiveness is analyzed using
the "standardized response mean" (SRM) statistic ("effi-
ciency" [37]), defined as the absolute value of mean
change (follow-up minus baseline scores) divided by the
SD of this change [21,38]. Confidence intervals of the
SRM are calculated assuming the change score is normally
distributed [39], and the SD of the change is treated as
constant for each outcome. SRMs of different measures
are compared by the modified jack-knife procedure as
described by Angst et al. [40].
"Internal" responsiveness on the individual level is
reported in this study by use of the "reliable change pro-
portion" statistic (RCP [6,41]). This is defined as the pro-
portion of patients improving from baseline to follow-up
by more than the smallest detectable difference. While the
SRM statistic is closely related to the ability to detect sta-
tistically significant differences based on group means and
between-patient variability, the RCP statistic relates in a
similar way to the ability to detect treatment effects in
individuals. According to the method described by David-
son and Keating [41], we report confidence intervals for
the "reliable change proportions", and compare estimates
for the different outcome measures by use of the
Cochrane Q test. When calculating RCP for SPADI, the
SDD estimate from the SPADI reproducibility substudy of
"stable" patients is used. For shoulder ROM, we use SDD
estimates obtained in a previously reported study [32]
regarding reproducibility of ROM in "stable" patients with
adhesive capsulitis.
"External responsiveness" [21] is investigated in this study
by calculating Pearson correlation coefficients (r) between
changes in SPADI and ROM for the affected shoulder. For
a more in-depth analysis of the relationship between
ROM and SPADI, we also perform multiple linear regres-
sion. SPADI improvement from baseline is the dependentBMC Musculoskeletal Disorders 2008, 9:161 http://www.biomedcentral.com/1471-2474/9/161
Page 4 of 8
(page number not for citation purposes)
variable, independent variables being baseline SPADI,
baseline C.AROM and C.AROM change.
All statistical analyses are carried out by using the software
package SPSS 13.0 for Windows®  (SPSS, Chicago, IL,
USA).
Results
Seventy-six patients were included in the clinical trial [20].
Fourteen of these patients were not able to take part in the
SPADI reproducibility substudy for practical reasons. Fur-
thermore, two patients did not respond to a sufficient
number of items at retest. Hence sixty patients were avail-
able for the SPADI reproducibility analysis. Details for
test/retest scores and reproducibility estimates for sub-
scales and SPADI total are given in Table 1. Distributions
of SPADI subscale and total scores on both occasions
approximate normal distributions according to plots (not
shown). Kolmogorov-Smirnov and Shapiro-Wilk tests
were non-significant except for the disability scale at
retest. Results indicate a "smallest detectable difference"
(SDD) of 17 points for the SPADI total score. This means
that for approximately 95% of the pairs of observations,
the difference between scores was 17 points or smaller.
The intraclass correlation coefficient (ICC) was 0.89.
Plotting SPADI means of the two observations against the
test-retest difference for each patient does not give any
indication that measurement errors vary systematically
over the range of possible scores (Figure 1).
Internal responsiveness
In the responsiveness substudy, all seventy-six patients
were included. One of them was not available for follow-
up. All other patients responded to a sufficient number of
items at follow-up to enable a SPADI score to be calcu-
lated. Hence seventy-five patients were available for the
responsiveness analysis. Patients in the two treatment
arms were pooled as there were no significant differences
in treatment effects [20]. Distributions of change scores
for ROM and SPADI subscale and total scores approxi-
mate normal distributions according to plots (not
shown). Kolmogorov-Smirnov and Shapiro-Wilk tests
were non-significant except for active abduction (A.ABD)
and active flexion (A.FLE).
Results for responsiveness of outcome measures are given
in Table 2. According to the modified jack-knife proce-
dure [40], the SPADI total was more responsive than all
single-movement ROM measures (p < 0.001 for all these
comparisons). The SPADI total was also more responsive
than combined ROM (p = 0.01 for C.PROM and p < 0.001
for C.AROM).
When addressing individual-level responsiveness, too,
SPADI was more responsive. The Cochrane Q test showed
a significantly higher reliable change proportion (RCP)
for the SPADI total score than for all single-movement
ROM-measures (p < 0.01 for all these comparisons, exact
test). The combined ROM measures were generally more
responsive than the corresponding single-movement
Table 1: SPADI test-retest reproducibility (n = 60)
Item/Subscale Obs. 1 Obs. 2 SDD ICC
Mean (SD) Mean (SD) (95% CI)
How severe is your pain:
01 At its worst? 7.2 (2.6) 7.4 (2.6)
02 When lying on the involved side? 6.7 (2.5) 6.9 (2.4)
03 Reaching for something on a high shelf? 7.4 (2.3) 7.7 (1.9)
04 Touching the back of your neck? 3.9 (3.3) 5.1 (3.1)
05 Pushing with the involved arm? 5.0 (2.9) 5.3 (3.1)
Pain score: 60.2 (19) 64.7 (21) 21 0.85 (0.76–0.91)
How much difficulty do you have:
06 Washing your hair? 5.5 (2.9) 5.6 (2.7)
07 Washing your back? 7.8 (2.3) 8.1 (1.9)
08 Putting on an undershirt or pullover sweater? 6.4 (2.2) 5.6 (2.3)
09 Putting on a shirt that buttons down the front? 3.6 (2.6) 3.9 (2.5)
10 Putting on your pants? 3.9 (3.0) 4.1 (3.0)
11 Placing an object on a high shelf? 7.8 (2.1) 8.1 (1.7)
12 Carrying a heavy object of 10 pounds? 5.8 (3.5) 6.2 (3.4)
13 Removing something from your back pocket? 6.7 (3.0) 6.8 (2.9)
Disability score: 59.1 (19) 60.3 (19) 20 0.86 (0.78–0.92)
SPADI score: 59.7 (17) 62.6 (19) 17 0.89 (0.82–0.93)
SD = between-subject standard deviation, SDD = smallest detectable difference, ICC = intraclass correlation coefficient.BMC Musculoskeletal Disorders 2008, 9:161 http://www.biomedcentral.com/1471-2474/9/161
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measures, but may be less responsive than the SPADI
total.
External responsiveness
Correlations (r) between changes in various ROM scores
and SPADI subscale and total scores were in the expected
direction, but for some movements the association was
weaker than anticipated (Table 3). As hypothesized, asso-
ciations with SPADI generally seem stronger for measures
of active ROM than for passive ROM, and stronger for the
disability subscale than for the pain subscale.
Results of the multiple linear regression analysis are given
in Table 4. At first we also included variables for passive
ROM (baseline and change for C.PROM), but these varia-
bles were omitted because the inclusion of these variables
did not result in a significant improvement of the model.
In the final model, 60% of the variance in SPADI
improvement could be explained by variance in the inde-
pendent variables, while only 40% could be explained if
improvement in C.AROM was omitted from the analysis.
Residuals were normally distributed and there was no evi-
dence of heteroscedasticity [35].
Discussion
The main finding in this study is that SPADI was more
responsive than measurements of shoulder ROM. Com-
paring responsiveness of a self-evaluation questionnaire
like SPADI and an impairment measure like shoulder
ROM may seem odd to some readers. Few researchers
have compared the responsiveness of shoulder scales with
the responsiveness of traditional shoulder outcome meas-
ures. However, this type of comparison was a natural
choice when investigating SPADI responsiveness in this
population. Both SPADI and shoulder ROM have been
used as outcome variables in several clinical trials involv-
ing patients with adhesive capsulitis. Furthermore, shoul-
der ROM was employed as a gold standard surrogate
when testing criterion validity and responsiveness of
SPADI in the original article by Roach et al. [1].
Reliability (reproducibility) is a necessary precondition
for the appropriate application of change scores in general
[42], but is especially important when interpreting change
scores for individual patients [43]. Investigation of SPADI
reproducibility with a test-retest design indicated that
approximately 95% of the pairs of observations did not
Test-retest reproducibility: Bland-Altman scatterplot show- ing mean SPADI value of both observations plotted against  the difference between observations for each patient (n =  60) Figure 1
Test-retest reproducibility: Bland-Altman scatter-
plot showing mean SPADI value of both observations 
plotted against the difference between observations 
for each patient (n = 60).
Table 2: Internal responsiveness of outcome measures (n = 75)
Baseline Follow-up Change SRM RCP
Mean (SD) Mean (SD) Mean (SD) (95% CI) (95% CI)
P. ABD 31.0 (11) 45.0 (13) 14.0 (11) 1.29 (1.06–1.52) 49% (38%–61%)
P. FLE 47.2 (16) 62.9 (13) 15.7 (16) 1.01 (0.78–1.24) 45% (34%–57%)
P. INT 33.0 (13) 47.1 (13) 14.1 (11) 1.29 (1.06–1.52) 47% (35%–58%)
P. EXT 17.4 (14) 27.9 (16) 10.5 (12) 0.85 (0.62–1.08) 33% (22%–44%)
A. ABD 55.9 (20) 84.7 (35) 28.8 (32) 0.91 (0.68–1.14) 59% (47%–70%)
A. FLE 88.1 (24) 116.8 (29) 28.7 (29) 0.99 (0.76–1.22) 48% (37%–60%)
A. INT 45.5 (15) 66.9 (17) 21.4 (15) 1.38 (1.15–1.61) 57% (46%–69%)
A. EXT 22.2 (15) 38.1 (19) 15.9 (14) 1.13 (0.90–1.36) 63% (52%–74%)
C. PROM 128.6 (43) 182.9 (44) 54.4 (36) 1.52 (1.29–1.75) 67% (56%–78%)
C. AROM 211.6 (60) 306.5 (88) 94.9 (74) 1.28 (1.05–1.51) 75% (65%–85%)
Pain score 62.4 (22) 21.8 (20) -40.6 (25) 1.62 (1.39–1.85) 77% (68%–87%)
Disability score 60.1 (20) 23.1 (19) -36.9 (21) 1.76 (1.53–1.99) 77% (68%–87%)
SPADI score 61.3 (20) 22.5 (18) -38.8 (21) 1.81 (1.58–2.04) 85% (76%–93%)
SD = between-subject standard deviation, CI = confidence interval, SRM = standardized response mean, RCP = reliable change proportion.BMC Musculoskeletal Disorders 2008, 9:161 http://www.biomedcentral.com/1471-2474/9/161
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differ by more than 17 points. This is slightly better than
what has previously been reported for other study popu-
lations where a similar design has been used [6,8,29].
Studying SPADI reproducibility, we observed a mean
score difference between the two administrations of the
questionnaire. The finding suggests some form of session
bias. One could suspect that ROM measurements on the
first test occasion caused temporarily increased pain in
some patients. Another possible explanation is that
patients were included early in the development of the
condition, so that a stable pain situation had not yet been
reached. Measurements in this study were analyzed
according to a simple one-way ANOVA model, and thus
we did not plan to control for a session effect. This means
that our results might tend to over-estimate measurement
errors. However, we analyzed data by a two-way ANOVA
model post-hoc, and results for reproducibility were very
similar to those reported in this study from the one-way
model analyses.
Estimates for reproducibility were used in subsequent
responsiveness analyses to produce a "reliable change
proportion" (RCP) figure for SPADI which was compared
with corresponding figures for shoulder ROM. A higher
RCP was found for SPADI than for the individual move-
ments of shoulder ROM. This could be interpreted either
as smaller measurement errors or as a larger "change" for
SPADI.
Group-level responsiveness was investigated by the
"standardized response mean" (SRM) statistic. Again, the
SPADI was more responsive than individual-movement
ROM measures. The combined ROM measures were also
generally more responsive than the individual-movement
measures, the reason for this being the relatively smaller
measurement errors for combined movements [32,44].
From purely statistical and practical points of view, the
SPADI appears as a more attractive outcome measure than
shoulder ROM in this study. The ratio of sample sizes
required to detect a given clinical effect is equal to the
square of the ratio of standardized response means [45].
Hence estimates for SRM indicate two- or three-fold
increases in necessary sample size if a single ROM move-
ment is chosen instead of SPADI as the primary outcome
measure in a trial of this type. Likewise, if SPADI and a
ROM measure are both used as outcome measures in a
trial, SPADI may have a better chance than the ROM
measure to detect a treatment effect. The possibility to
detect a significant difference is one thing, however. When
comparing responsiveness of ROM and SPADI in this way,
we compare the ability to detect change, but we are not
comparing the ability to detect the same change. We ana-
lyze the change in scales which do not measure the same
construct. Clearly, the aim of each separate study must
guide in the selection of outcome measures.
Compared to previous studies reporting SRM for SPADI,
estimates in this population are high. Five previous stud-
ies report much lower SRMs [6,7,9,11,34], while in a
recently published study [10], SRM for SPADI was almost
as high as in this study. The researchers also reported
responsiveness of the cASES "Motion active" (SRM: 1.54)
and "Motion passive" (SRM: 1.47), which are constructs
that (roughly) correspond to the constructs C.AROM
(SRM: 1.28) and C.PROM (SRM: 1.52) in the present
study. Responsiveness for these ROM measures is quite
similar in the two studies, and in both studies lower than
Table 3: Correlation (r) of ROM and SPADI change after treatment (n = 75)
Examined movement Pain subscale Disability subscale SPADI total
P. ABD -0.26 -0.28 -0.29
P. FLE -0.03 -0.09 -0.09
P. INT -0.02 -0.15 -0.09
P. EXT -0.15 -0.33 -0.25
C. PROM -0.15 -0.29 -0.23
A. ABD -0.31 -0.32 -0.33
A. FLE -0.30 -0.36 -0.35
A. INT -0.14 -0.31 -0.23
A. EXT -0.22 -0.33 -0.29
C. AROM -0.32 -0.40 -0.38
Table 4: Results of linear regression analysis (n = 75)
B SE of B β Sig.
Constant -40 11 0.001
Baseline SPADI 0.80 0.091 0.75 < 0.001
Baseline C.AROM 0.082 0.031 0.23 0.01
C. AROM improvement 0.13 0.022 0.46 < 0.001
SD = between-subject standard deviation, CI = confidence interval, 
SRM = standardized response mean, RCP = reliable change 
proportion.BMC Musculoskeletal Disorders 2008, 9:161 http://www.biomedcentral.com/1471-2474/9/161
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the SPADI total. However, results for responsiveness are in
general specific to the study population, the intervention
and the overall design of the study. Comparisons across
studies are difficult.
In this study, confidence intervals and test statistics for the
SRM and RCP are calculated as if the estimated variability
in scores (SD of change and SDD, respectively) represents
the underlying "true" variability. This is an approxima-
tion. A more exact method would probably result in wider
confidence intervals and more conservative test results.
Investigation of "external" responsiveness is sometimes
performed in order to demonstrate that a new measure
may replace an old one. This was not really our aim: we
simply wanted to investigate the relationship between
changes in shoulder ROM and SPADI in these patients.
Since there is no valid way to measure change directly
[42], comparisons were based on the difference between
respective measurements for the two different time points.
Correlations between improvement in ROM and SPADI
were below 0.50. In the original study by Roach et al. [1],
associations between SPADI and active ROM change
scores were stronger, coefficients ranging from -0.52 to -
0.70. Limited information regarding the variability of
change scores in that study restricts further comparisons,
however.
The ability to discern associations among variables is
impaired by a lack of reproducibility in direct proportion
to the products of the reliabilities of the measurements
involved [46]. Furthermore, one must expect the reliabil-
ity of a difference between measurements to be lower than
the reliability of the separate measurements [44]. Hence
there is reason to believe that the association between
"true" changes for ROM and SPADI is somewhat stronger
than indicated by the correlation coefficients reported in
this study.
Of the translation process, the Stage VI (submission of
reports to the developers of the original questionnaire)
was not performed, and this is a weakness of the study. We
were not able to get in contact with the respective
researchers.
Conclusion
Results indicate that SPADI is more responsive than
shoulder ROM measurements, which have been exten-
sively employed as shoulder outcome variables in these
patients. The relationship between changes in shoulder
ROM and SPADI suggest that they measure overlapping
underlying phenomena. The results in this study support
incorporating the SPADI questionnaire in patient evalua-
tion procedures when designing clinical trials where
patients with adhesive capsulitis are investigated.
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